Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Studies in knock-out mice confirmed the biological action of [dA(2)]GLP-1/GcG which is related to its ability to target GIP, GLP-1, and glucagon receptors
Here we report the design and preclinical evaluation of a unimolecular quintuple agonist, which via covalent binding of Lani to a GLP-1RGIPR co-agonist allows for its targeted delivery into cells that express the receptor for GLP-1 or GIP
It continuously remodels to adapt to mechanical stress and maintain skeletal integrity
The drugs have been used to treat diabetes for a couple decades now, but with the realization that they can have a significant impact on weight loss, the interest in this class of medications has shot up
US$ 27.36
US$ 20.87
US$ 22.23
US$ 20.86
US$ 23.83
US$ 22.32
